Method for Analyzing and Isolating Stem Cells

Information

  • Research Project
  • 6787985
  • ApplicationId
    6787985
  • Core Project Number
    R43CA108128
  • Full Project Number
    1R43CA108128-01
  • Serial Number
    108128
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2004 - 20 years ago
  • Project End Date
    5/31/2005 - 19 years ago
  • Program Officer Name
    CHEUNG, GEOFFREY P.
  • Budget Start Date
    6/1/2004 - 20 years ago
  • Budget End Date
    5/31/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/14/2004 - 20 years ago
Organizations

Method for Analyzing and Isolating Stem Cells

DESCRIPTION (provided by applicant): Since human pluripotent stem cells were first isolated, research on stem cells has received much public attention, because of the extraordinary importance for fundamental studies and the potential of using these cells in numerous clinical applications. Stem cell differentiation is the process by which an unspecialized cell becomes specialized into one of many cell types of the organism, all possessing specific functions. The possibility of manipulating this process in vitro provides opportunities for using isolated stem cells for different therapeutic applications, including stem cell transplantation to treat degenerated or malignant disorders. In vivo maturation and differentiation of hematopoietic cells is regulated by a variety of mechanisms, which include growth factors, chemokines, and cytokines released by accessory cells and, more importantly, by hematopoietic cells themselves. Methods used for monitoring the effectiveness of this process and isolating viable cells of interest are complicated, laborious and time consuming. Using single cell encapsulation technology, immunophenotyping and flow cytometry, this Small Business Innovation Research application proposes to develop a rapid and sensitive method for isolating stem cells of interest for use in various therapeutic applications.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    164290
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:164290\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ONE CELL SYSTEMS, INC
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES